Preformed IgG Antibodies Against Major Histocompatibility Complex Class II Antigens Are Major Risk Factors for High-grade Cellular Rejection in Recipients of Heart Transplantation
- 25 August 1998
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 98 (8) , 786-793
- https://doi.org/10.1161/01.cir.98.8.786
Abstract
Background—Preformed anti-HLA antibodies reacting specifically with donor lymphocytes have been associated with acute vascular rejection and early cardiac allograft failure. However, the effect of ...Keywords
This publication has 13 references indexed in Scilit:
- Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts.Journal of Clinical Investigation, 1998
- NEW STRATEGIES FOR EARLY DIAGNOSIS OF HEART ALLOGRAFT REJECTION1Transplantation, 1997
- Epitope spreadingCurrent Opinion in Immunology, 1996
- Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome?The Journal of Thoracic and Cardiovascular Surgery, 1996
- Indirect recognition of donor HLA-DR peptides in organ allograft rejection.Journal of Clinical Investigation, 1996
- The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantationTransplant Immunology, 1993
- OUTCOME OF CARDIAC TRANSPLANT RECIPIENTS WITH A POSITIVE DONOR-SPECIFIC CROSSMATCH—PRELIMINARY RESULTS WITH PLASMAPHERESISTransplantation, 1992
- THE ROLE OF ANTI-HLA ANTIBODIES IN HEART TRANSPLANTATIONTransplantation, 1991
- Regression Analysis of Multivariate Incomplete Failure Time Data by Modeling Marginal DistributionsJournal of the American Statistical Association, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958